From the Journals

AML leads percent gains in 5-year survival among leukemias


 

Over the 60-year span from the early 1950s to 2013, the 5-year survival rate for all leukemias increased by 500%, according to data from the Surveillance, Epidemiology, and End Results Program.

For 2008-2013, the 5-year relative survival rate for all leukemias was 60.1%, compared with 10% during 1950-1954, said Ali H. Mokdad, PhD, and his associates at the Institute for Health Metrics and Evaluation at the University of Washington, Seattle (JAMA 2017;317[4]:388-406).

Five-year survival rate for all leukenia up 500%
Data for the various types of leukemia were not available for 1950-1954, so the changes in the 5-year survival for those included in the study are calculated from 1973-1977 to 2008-2013. Chronic lymphoid leukemia (CLL) had the highest survival rate at both time periods and the smallest increase at 23%. Acute lymphoid leukemia (ALL) had a 74% increase in survival, chronic myeloid leukemia (CML) had a 215% increase in survival, and acute myeloid leukemia (AML) had the largest increase at 342%, the investigators reported.

Recommended Reading

Drugs approved in 2013
MDedge Internal Medicine
Melanoma twice as likely after CLL/SLL than other types of NHL
MDedge Internal Medicine
CLL patients achieve remission with CAR-modified T-cells
MDedge Internal Medicine
Ibrutinib approved as first-line therapy for all CLL patients
MDedge Internal Medicine
FDA approves venetoclax for CLL with 17p deletion
MDedge Internal Medicine
Maintenance rituximab extends progression-free but not overall survival in CLL
MDedge Internal Medicine